Have you heard of our loan programs?
At AMSL Diabetes, we strive to complement patient freedom and remove barriers to access to advanced diabetes management technology. We're excited to introduce two tailored loan streams for t:slim X2 insulin pump, aimed at supporting early initiation and flexible management for Type 1 diabetes patients.
Give it a Try
The Give it a Try initiative allows a two-month trial with the t:slim X2 insulin pump, subject to application approval and certain conditions. It provides an opportunity for individuals to experience the pump's benefits first hand.
Key features
For anyone with Type 1 Diabetes to trial pump therapy. Does not require Private Health Insurance.
Get in touch with us for more information or to find out how to apply.
Accelerate & Pump
Don't wait for health insurance to mature, loan a t:slim X2 insulin pump through the AMSL Diabetes Accelerate & Pump program.
Key features
For those awaiting maturity of Private Health Insurance.
Get in touch with us for more information or to find out how to apply.
**Additional feature updates are subject to future regulatory approvals. Control-IQ technology is not a substitute for active self-management of your diabetes. Control-IQ technology is only available with Dexcom G6 CGM. Dexcom G6 CGM sold separately.
1. Forlenza GP, Li Z, Buckingham BA, Pinsker JE, et al. Predictive low-glucose suspend reduces hypoglycaemia in adults, adolescents, and children with type 1 diabetes in an at-home randomized crossover study: Results of the PROLOG trial. Diabetes Care. 2018;41(10):2155-2161. doi:10.2337/dc18-0771.